People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Myrtelle Inc. | — | Biotechnology | Series B | $73.2M | $117.1M | 2024 |
Fay Xing at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Fay Xing on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Huang | 1 | 5 |
| Thomas Barton | 1 | 4 |
| Michael Muhonen | 1 | 2 |
| Chrystyna Bedrij | 1 | 2 |
| Laurie Playtek | 1 | 2 |
| Laurie Platek | 1 | 2 |
| Mark Pykett | 1 | 2 |
| Adrian Stecyk | 1 | 1 |
| Debra Yu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.